ImageneBio, Inc.
IMA
$5.83
-$0.19-3.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -52.61% | 547.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -68.02% | 261.38% | |||
| Operating Income | 68.02% | -261.38% | |||
| Income Before Tax | 71.09% | -227.66% | |||
| Income Tax Expenses | -272.97% | -- | |||
| Earnings from Continuing Operations | 72.12% | -226.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 72.12% | -226.68% | |||
| EBIT | 68.02% | -261.38% | |||
| EBITDA | 69.50% | -261.45% | |||
| EPS Basic | 77.69% | 60.48% | |||
| Normalized Basic EPS | 76.08% | 45.75% | |||
| EPS Diluted | 77.69% | 60.48% | |||
| Normalized Diluted EPS | 76.08% | 45.75% | |||
| Average Basic Shares Outstanding | 20.83% | 504.05% | |||
| Average Diluted Shares Outstanding | 20.83% | 504.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||